Form 4: Artiva Biotherapeutics Executive Sells Shares
Insider Transaction (Form 4)
Subhashis Banerjee, Chief Medical Officer of Artiva Biotherapeutics, Inc., sold 8,222 shares of common stock on August 27, 2026 for $12.01 per share.
Summary
- Option exercise/conversion: acquired 5,306 Common Stock at $1.92 ($10,188) on August 27, 2026; holds 150,269 after (Direct).
- Open-market sale: disposed of 8,222 Common Stock at $12.01 ($98,736) on August 27, 2026; holds 142,047 after (Direct).
- Option exercise/conversion: disposed of 5,306 Employee Stock Option (Right to Buy) on August 27, 2026; holds 74,265 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $98,736 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Subhashis Banerjee — Officer (Chief Medical Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Option exercise/conversion | Common Stock | 5,306 | $2 | $10.2K | 150,269 |
| 2026-08-27 | Open-market sale | Common Stock | 8,222 | $12 | $98.7K | 142,047 |
| 2026-08-27 | Option exercise/conversion | Employee Stock Option (Right to Buy) | 5,306 | — | — | 74,265 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Option exercise/conversion (5,306 shares) |
| 2026-08-27 | Open-market sale (8,222 shares) |
| 2026-08-27 | Option exercise/conversion (5,306 shares) |
Keywords
insider transaction, Form 4, ARTV, Artiva Biotherapeutics, Inc., bearish, Subhashis Banerjee
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.